Fujirebio asked the FDA to approve its blood test for Alzheimer's disease, which would be the first commercially available test of its kind.| Alzheimer's News Today
Blood levels of two proteins, known as MMP9 and APP, could serve as biomarkers for fragile X syndrome where genetic testing is not possible.| Fragile X News Today
Ampel BioSolutions is launching LuGENE, a lupus blood test that uses AI to look at gene activity to predict flares and personalize treatments.| Lupus News Today